Filtros de búsqueda

Lista de obras de

A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex

artículo científico publicado en 2019

An overview of health issues and development in a large clinical cohort of children with Angelman syndrome

artículo científico publicado en 2019

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1

artículo científico publicado en 2015

Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1

artículo científico publicado en 2016

Development of emotional and behavioral problems in neurofibromatosis type 1 during young childhood.

artículo científico publicado en 2017

Early brain magnetic resonance imaging findings and neurodevelopmental outcome in children with congenital heart disease: A systematic review

scientific article published in 2023

Emotional and behavioral problems in children and adolescents with neurofibromatosis type 1.

artículo científico publicado en 2017

Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.

artículo científico publicado en 2015

Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives

artículo científico publicado en 2019

Motor problems in children with neurofibromatosis type 1.

artículo científico publicado en 2017

Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial

artículo científico publicado en 2013

Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.

artículo científico publicado en 2016

Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based.

artículo científico publicado en 2014

Worries and needs of adults and parents of adults with neurofibromatosis type 1.

artículo científico publicado en 2018